Kevin A. Lobo became CEO in October 2012, and Chair of the Board in July 2014.
Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics.
Mr. Lobo is the chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and serves on the board of directors for Parker Hannifin Corporation, the global leader in motion and control technologies, and the U.S.-India Business Council. He is also a member of the Business Roundtable and Business Council.
Mr. Lobo has a broad business career that includes executive positions in general management and finance. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including roles based in Europe as Corporate Controller of Rhodia, the chemical spin-out, and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President of J&J Medical Canada and President of Ethicon Endo Surgery.